LAVIPHARM S.A. NA EO 1 (BXA0) — Working Capital to Net Assets Ratio

LAVIPHARM S.A. NA EO 1 (BXA0) has a Working Capital to Net Assets ratio of 11.1% as of December 2024. Working capital of €5.88 Million (current assets of €45.00 Million minus current liabilities of €39.12 Million) is measured against net assets of €52.97 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See LAVIPHARM S.A. NA EO 1 financial flexibility index to measure the company's free cash flow as a share of total liabilities.